UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 23, 2021 4:30 P.M.

Form:	S-3
CIK: 0001693011 Company Name: Inozyme Pharma, Inc. File Number: 333-258702